With a view to provide better understanding of the biosimilars industry, Virtue Insight is organising the 5th Biosimilars Congregation 2014 at Kohinoor Continental Hotel, Mumbai on September 10, 2014.

This event will bring in experts from the industry from across the world under one roof to deliberate and analyse advanced commercial developments an  identify successful management strategies of biosimilars.

Industry experts will discuss on subjects ranging from commercialisation and development strategies to gain a competitive advantage to calculating possible revenue streams from biosimilar production. There would be brainstorming discussion on how should the pharma and generics industries approach the quickly emerging and developing biosimilar market and on what is the future of next generation biosimilars.

One of the important aspect of the event is that it would highlight the commercial challenges and opportunities to develop biosimilars, while stressing on the growing importance of biobetters over biosimilars. All the participants are expected to gain in-depth knowledge on role of technology transfer, its affect market access, policy makers role in shaping the contours of this new generic frontier, and the probable implications they may have for present biologic drug development and patent protection.

The meet will also focus on the next generation monoclonal antibody development and clinical challenges faced with biosimilar drug development, technical case study for analytical and clinical comparability strategies, the legal/IP for biosimlars and how to maximise strategic partnerships to enter into the biosimlar market. New frontiers in cell line development and opportunities in biosimilars, will also be explored while discussing on how to reach the target audience more effectively and quickly.